Loren W. Wass - Chief Commercialization Officer at Bionik Laboratories Corp.

Issuer-level insider activity

Role
Chief Commercialization Officer
Issuer ticker
BNKL
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Loren W. Wass since 22 Jul 2025

Reported holdings for Loren W. Wass in Bionik Laboratories Corp.

Form 4 holding Chief Commercialization Officer

Bionik Laboratories Corp.

Security class
Employee Stock Option (right to buy)
Shares / value
55,000
Estimated value
Report date
14 Oct 2021
Price
Ownership
Direct
Underlying class
Common Stock, par value $0.001
Underlying amount

Transaction history for Loren W. Wass in Bionik Laboratories Corp.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .